Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.
Lloyd PC, Hu M, Wong HL, Shoaibi A, Ke Zhou C, Lo AC, Amend K, Beachler DC, McMahill-Walraven CN, Smith ER, Seeger J, Secora A, Audrey Djibo D, Obidi J, Feng Y, Song J, Reich C, Harris C, Akhtar S, Clifford R, Selvam N, Pigoga JL, Jiao Y, Chillarige Y, MaCurdy T, Forshee R, Anderson SA. Lloyd PC, et al. Among authors: shoaibi a. Vaccine. 2022 Oct 26;40(45):6481-6488. doi: 10.1016/j.vaccine.2022.09.060. Epub 2022 Sep 27. Vaccine. 2022. PMID: 36195472 Free PMC article.
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.
Bell C, Chakravarty A, Gruber S, Heckbert SR, Levenson M, Martin D, Nelson JC, Pinheiro S, Psaty BM, Reich CG, Schneeweiss S, Shoaibi A, Toh S, Walker AM. Bell C, et al. Among authors: shoaibi a. Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1223-5. doi: 10.1002/pds.3712. Epub 2014 Sep 29. Pharmacoepidemiol Drug Saf. 2014. PMID: 25263307 No abstract available.
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.
Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM. Chrischilles EA, et al. Among authors: shoaibi a. Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018 Jan 10. Pharmacoepidemiol Drug Saf. 2018. PMID: 29318683
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
Wong HL, Hu M, Zhou CK, Lloyd PC, Amend KL, Beachler DC, Secora A, McMahill-Walraven CN, Lu Y, Wu Y, Ogilvie RP, Reich C, Djibo DA, Wan Z, Seeger JD, Akhtar S, Jiao Y, Chillarige Y, Do R, Hornberger J, Obidi J, Forshee R, Shoaibi A, Anderson SA. Wong HL, et al. Among authors: shoaibi a. Lancet. 2022 Jun 11;399(10342):2191-2199. doi: 10.1016/S0140-6736(22)00791-7. Lancet. 2022. PMID: 35691322 Free PMC article.
Characterization of test positivity among patients with coronavirus disease 2019 (COVID-19) in three electronic health records databases, February-November 2020.
Saunders-Hastings P, Zhou CK, Hobbi S, Wong HL, Lloyd P, Boyd E, Alawar N, Clarke TC, Beers J, Burrell T, Shoaibi A. Saunders-Hastings P, et al. Among authors: shoaibi a. BMC Public Health. 2022 Jun 18;22(1):1217. doi: 10.1186/s12889-022-13635-6. BMC Public Health. 2022. PMID: 35717174 Free PMC article.
147 results